MK
Mahesh Kumar Kantilal Bhalgat
About Mahesh Kumar Kantilal Bhalgat
Data last updated:
Mahesh Kumar Kantilal Bhalgat has 11 years in corporate governance. Formerly with 5 companies, such as Sanofi Healthcare India Private Limited and Syngene Manufacturing Solutions Limited. Engaged in Healthcare, General Business. Contributes to corporate operations.
Current companies
Previous companies
| Company | Designation | Appointment | Founded | Status |
|---|---|---|---|---|
 Sanofi Healthcare India Private Limited U24110MH1993PTC332584 | Whole-Time Director | 29 Sep 2015 | 1993 | Active |
 Syngene Manufacturing Solutions Limited U24290KA2022PLC165409 | Director | 26 Aug 2022 | 2022 | Under Liquidation |
 Veeda Clinical Research Limited U73100GJ2004PLC044023 | Additional Director | 09 May 2024 | 2004 | Active |
| Syngene Scientific Solutions Limited U73200KA2022PLC164804 | Director | 10 Aug 2022 | 2022 | Active |
| Ingenuity Biosciences Private Limited U74999GJ2021PTC120292 | Additional Director | 14 Apr 2025 | 2021 | Active |
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Mahesh Kumar Kantilal Bhalgat
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Mahesh Kumar Kantilal Bhalgat
Mahesh Kumar Kantilal Bhalgat has 11 years in corporate governance. Formerly with 5 companies, such as Sanofi Healthcare India Private Limited and Syngene Manufacturing Solutions Limited. Engaged in Healthcare, General Business. Contributes to corporate operations.
Mahesh Kumar Kantilal Bhalgat is associated with 0 companies as a director.
Mahesh Kumar Kantilal Bhalgat has expertise in Healthcare, General Business.
Mahesh Kumar Kantilal Bhalgat has 11 years in corporate governance.